| Trends in prevalence and incidence of alopecia areata, alopecia totalis, and alopecia universalis among adults and children in a US employer-sponsored insured population A Mostaghimi, W Gao, M Ray, L Bartolome, T Wang, C Carley, N Done, ... JAMA dermatology 159 (4), 411-418, 2023 | 32 | 2023 |
| All-cause health care resource utilization and costs among adults with alopecia areata: a retrospective claims database study in the United States A Mostaghimi, K Gandhi, N Done, M Ray, W Gao, C Carley, T Wang, ... Journal of Managed Care & Specialty Pharmacy 28 (4), 426-434, 2022 | 11 | 2022 |
| Real-world healthcare resource utilization and costs associated with tisagenlecleucel and axicabtagene ciloleucel among patients with diffuse large B-cell lymphoma: an analysis … RT Maziarz, H Yang, Q Liu, T Wang, J Zhao, S Lim, S Lee, A Dalal, ... Leukemia & Lymphoma 63 (9), 2052-2062, 2022 | 10 | 2022 |
| P1111: comparative efficacy and safety of tisagenlecleucel and axicabtagene ciloleucel in relapsed/refractory follicular lymphoma M Dickinson, J Martinez-Lopez, E Jousseaume, C Anjos, H Yang, X Chai, ... Hemasphere 6, 1001-1002, 2022 | 7 | 2022 |
| Healthcare utilization and costs among US adolescents with alopecia areata M Ray, E Swallow, K Gandhi, C Carley, V Sikirica, T Wang, N Done, ... Journal of Health Economics and Outcomes Research 9 (2), 11, 2022 | 6 | 2022 |
| The economic burden of recurrence in triple-negative breast cancer among working age patients in the United States J Sieluk, Y Song, J Freimark, M Huang, A Haiderali, R Berman, T Wang, ... Advances in therapy, 1-16, 2022 | 4 | 2022 |
| Nivolumab versus placebo as adjuvant therapy for resected stage III melanoma: a propensity weighted indirect treatment comparison and number needed to treat analysis for … JS Weber, T Poretta, BD Stwalley, LA Sakkal, EX Du, T Wang, Y Chen, ... Cancer Immunology, Immunotherapy 72 (4), 945-954, 2023 | 2 | 2023 |
| Real-world treatment patterns among patients with alopecia areata in the USA: a retrospective claims analysis D Nicolae, L Bartolome, E Swallow, GAO Wei, C Carley, W Travis, ... Acta Dermato-Venereologica 103, 2023 | 2 | 2023 |
| PCN248 productivity costs associated with disease recurrence among surgically-treated patients with triple-negative breast cancer J Sieluk, A Haiderali, M Huang, K Hirshfield, J Signorovitch, Y Song, ... Value in Health 24, S66, 2021 | 1 | 2021 |
| Incidence of pneumococcal disease in children≤ 48 months old in the United States: 1998–2019 S Mohanty, N Done, Q Liu, Y Song, T Wang, K Gaburo, EM Sarpong, ... Vaccine, 2024 | | 2024 |
| Comparative efficacy and safety of tisagenlecleucel and axicabtagene ciloleucel among adults with r/r follicular lymphoma M Dickinson, J Martinez-Lopez, E Jousseaume, H Yang, X Chai, C Xiang, ... Leukemia & Lymphoma 65 (3), 323-332, 2024 | | 2024 |
| Development of a prediction model for hypereosinophilic syndrome using real-world data D Carstens, P Ogbogu, Y Chung, M Cheng, E Cook, F Mu, E Judson, ... Journal of Allergy and Clinical Immunology 153 (2), AB216, 2024 | | 2024 |
| Characteristics of patients with hypereosinophilic syndrome in a large US cohort D Carstens, P Ogbogu, Y Chung, M Cheng, E Cook, F Mu, E Judson, ... Journal of Allergy and Clinical Immunology 153 (2), AB217, 2024 | | 2024 |
| Patient characteristics associated with all-cause healthcare costs of alopecia areata in the United States W Gao, A Mostaghimi, K Gandhi, N Done, M Ray, J Signorovitch, ... Journal of Medical Economics 26 (1), 441-444, 2023 | | 2023 |
| 1693. Incidence of Pneumococcal Disease in Children≤ 48 Months Old in the United States: 2010-2019 S Mohanty, N Done, Q liu, Y Song, K Gaburo, T Wang, EM Sarpong, ... Open Forum Infectious Diseases 10 (Supplement_2), ofad500. 1526, 2023 | | 2023 |
| 534. Healthcare Resource Utilization and Costs among Patients with COVID-19 in the United States G Liu, N Done, Y Song, H Goswami, T Wang, H Li, M Mattera, ... Open Forum Infectious Diseases 10 (Supplement_2), ofad500. 603, 2023 | | 2023 |
| Cytochrome P450--inhibiting/inducing Medication Use Among Patients With Advanced Ovarian Cancer (aOC) Who Received or Were Eligible for Poly (ADP-ribose) Polymerase Inhibitors … BJ Rimel, D Chase, J Perhanidis, AA Ghazarian, E Xiaoyan Du, T Wang, ... Journal of Oncology Navigation & Survivorship 14 (11), 2023 | | 2023 |
| HSD35 Real-World Treatment Patterns Among US Adolescents with Alopecia Areata: A Retrospective Claims Analysis N Done, M Ray, W Gao, T Wang, C Carley, L Bartolome, E Swallow, ... Value in Health 25 (7), S486, 2022 | | 2022 |
| Comparative Efficacy and Safety of Tisagenlecleucel (tisa-cel) and Axicabtagene Ciloleucel (axi-cel) in Relapsed/Refractory Follicular Lymphoma (r/r FL) M Dickinson, J Martinez-Lopez, E Jousseaume, C Anjos, H Yang, X Chai, ... 2022 Tandem Meetings| Transplantation & Cellular Therapy Meetings of ASTCT …, 2022 | | 2022 |
| Propensity weighted indirect treatment comparison of nivolumab (NIVO) versus placebo (PBO) as adjuvant therapy for resected melanoma: A number needed to treat and overall … JS Weber, T Poretta, B Stwalley, L Sakkal, EX Du, T Wang, Y Chen, ... Journal of Clinical Oncology 39 (15_suppl), 9572-9572, 2021 | | 2021 |
